OBL astigmatism could require additional correction

Article

Correcting pre-existing astigmatism could be necessary for achieving excellent visual outcomes in eyes with oblique (OBL) astigmatism.

Correcting pre-existing astigmatism could be necessary for achieving excellent visual outcomes in eyes with oblique (OBL) astigmatism.

A team headed by Dr Hidenaga Kobashi, Department of Ophthalmology, University of Kitasato School of MedicineKanagawa, Japan, conducted an investigational simulation on 38 healthy participants with no ophthalmic complaints apart from refractive errors.

Cycloplegic refraction was fully corrected in all volunteers with a 3.0 mm artificial pupil. With-the-rule (WTR), against-the-rule (ATR), and oblique (OBL) astigmatism of 1.0 D, 2.0 D and 3.0 D were created using trial lenses in all participants.

Trial lenses under cycloplegia enforced distance visual acuity and visual performance with uncorrected astigmatism. The Minnesota Low Vision Reading Test acuity charts were used to assess maximum reading speed and reading acuity was used to determine reading performance.

Axis orientation at each dioptre of astigmatism significantly affected distance visual acuity, reading acuity and maximum reading speed with uncorrected astigmatism. Significantly better values were identified in eyes with WTR or ATR astigmatism in all parameters, compared to eyes with OBL astigmatism.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.